Prof Dr Yusuf Yılmaz
Marmara Üniversitesi
H-index: 54
Asia-Turkey
Top articles of Prof Dr Yusuf Yılmaz
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Steatotic liver disease as a new nomenclature for NAFLD from the perspectives of the MENA region: One size fits all this time | Journal of Hepatology | Mohamed El-Kassas Khalid Alswat Mina Tharwat Asma Labidi Mohammed A Medhat | 2024/2/1 |
Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: results from a single-center biopsy study | Chinese Medical Journal | Eda Kaya Yusuf Yilmaz | 2024/2/6 |
Clinical and patient‐reported outcomes in patients with chronic hepatitis B and C and non‐alcoholic fatty liver disease from real‐world practices in Saudi Arabia, Turkey and Egypt | Journal of Viral Hepatitis | Saleh A Alqahtani Yusuf Yilmaz Mohamed El‐Kassas Khalid Alswat Faisal Sanai | 2024/4/15 |
Prevalence, determinants, and fibrosis risk stratification of metabolic-associated fatty liver disease in a Turkish primary care setting: a retrospective study | Hepatology | Ayse Yazan Arslan Sultannur Celik Fatuhulah Amin Ilayda Caylak Irem Kesapli | 2024 |
Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa | Zobair M Younossi Pegah Golabi James Paik Soroor Owrangi Yusuf Yilmaz | 2024/2/2 | |
Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis | Liver international | Ferenc E Mózes Jenny A Lee Yasaman Vali Emmanuel A Selvaraj Arjun NA Jayaswal | 2024/4/4 |
Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in primary biliary cholangitis | Digestive and Liver Disease | GF Manfredi I Ergenç MG Cittone R Bertetto C De Benedittis | 2024/2/1 |
Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action | Hepatology Forum | Lubna Kamani Adeel Rahat Yusuf Yilmaz | 2024 |
The Impact of Stigma on Quality of Life and Liver Disease Burden Among Patients with Nonalcoholic Fatty Liver Disease | JHEP Reports | Zobair M Younossi Saleh A AlQahtani Jesús Funuyet-Salas Manuel Romero-Gómez Yusuf Yilmaz | 2024/3/12 |
Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Cognitive Impairment and All-Cause Dementia: A Comprehensive Review | Frontiers in Public Health | Weitao Su Minhui Chen Ling Xiao Shanshan Du Lihua Xue | 2022/11/7 |
Vibration-controlled transient elastography for non-invasive screening of liver fibrosis and steatosis in Turkish patients with psoriasis: A cross-sectional study | Hepatology Forum | Ahsen Nihal Aksoy Burak Hanci Mehmet Furkan Baskent Emine Gul Umutlu Eda Nur Kumas | 2024 |
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease | Journal of hepatology | Zobair M Younossi Saleh A Alqahtani Khalid Alswat Yusuf Yilmaz Caglayan Keklikkiran | 2024/3/1 |
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement | Hepatology communications | Hannes Hagström Leon A Adams Alina M Allen Christopher D Byrne Yoosoo Chang | 2024/2/1 |
Predicting fibrosis progression in non-alcoholic fatty liver disease patients using the FAST Score: A paired biopsy study | Hepatology Forum | Nisanur Sariyar Haluk Tarik Kani Cigdem Ataizi Celikel Yusuf Yilmaz | 2024 |
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis | New England Journal of Medicine | Gideon M Hirschfield Christopher L Bowlus Marlyn J Mayo Andreas E Kremer John M Vierling | 2024/2/21 |
The Global Survey of Disease Burden and Stigma in NAFLD | Zobair M Younossi Yusuf Yilmaz Jian-Gao Fan Ming-Hua Zheng Khaled Alsawat | 2023 | |
Geographical similarity and differences in the burden and genetic predisposition of NAFLD | Terry Cheuk‐Fung Yip Eduardo Vilar‐Gomez Salvatore Petta Yusuf Yilmaz Grace Lai‐Hung Wong | 2023/4/1 | |
Stigma in NAFLD and NASH: a global survey of patients and providers | J Hepatol | Zobair Younossi Yusuf Yılmaz Jian-Gao Fan Vincent Wai-Sun Wong Mohamed El Kassas | 2023/6/1 |
A multisociety Delphi consensus statement on new fatty liver disease nomenclature | Mary E Rinella Jeffrey V Lazarus Vlad Ratziu Sven M Francque Arun J Sanyal | 2023/12/1 | |
The heated debate over NAFLD renaming: An ongoing saga | Hepatology Forum | Yusuf Yilmaz | 2023 |
